Andrews, Lori. 1986. “My Body, My Property.” Hastings Center Report. 16:28–38.
Annas, George. 1993. “Outrageous Fortune: Selling Other People's Cells.” In Standard of Care: The Law of American Bioethics, 167–177. Oxford: Oxford University Press.
Appleyard, Brian. 1997. “Dead and Alive: The Woman Who Won't Die.” The Australian Magazine, April 26–27, 34–40.
Beck, Ulrich. 1992. Risk Society: Towards a New Modernity. London: Sage Publications.
Blumberg, Baruch S., Irving, Millman, Thomas, London W., and Other Members of the Division of Clinical Research, Fox Chase Cancer Center. 1985. “Ted Slavin's Blood and the Development of HBV Vaccine.” New England Journal of Medicine 312:189.
Bodnar, A. G., Ouellete, M., Frolkis, M., Holt, S. E., Chiu, C. P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., and Wright, W. E. 1998. “Extension of Life-Span by Introduction of Telomerase into Normal Human Cells.” Science 279:349–52.
Boyle, James. 1996. Shamans, Soft ware and Spleens: Law and the Construction of the Information Society. Cambridge, Massachusetts: Harvard University Press.
Bray, Michelle Bourianoff. 1990. “Personalizing Personality: Toward a Property Right in Human Bodies.” Texas Law Review 69:209–244.
Cambrosio, Alberto, and Peter, Keating. 1995. Exquisite Specificity: The Monoclonal Antibody Revolution. Oxford: Oxford University Press.
Cannon, James R. 1994. “Novelty and the Public Domain.” In The Law and Strategy of Biotechnology Patents, edited by Kenneth, D. Sibley, 75–92. Boston: Butterworth-Heinemann.
Chen, Irvin S. Y., Shirley, G. Quan, and David, W. Golde. 1983. “Human T-cell leukemia virus type II transforms normal human lymphocytes.” Proceedings of the National Academy of Sciences, USA 80:7006–7009.
Erin, Charles. 1994. “Who Owns Mo?” In Ethics and Biotechnology, edited by Anthony, Dyson and John, Harris, 157–178. New York: Routledge.
Franklin, Sarah. 1997. “Dolly: a New Form of Transgenic Breedwealth.” Environmental Values 6: 427–37.
Gasson, Judith C., Irvin, S. Y. Chen, Carol, A. Westbrook, David, W. Golde. 1983. “Lymphokines and Hematopoiesis.” In Normal and Neoplastic Hematopoiesis, edited by David, W. Golde and Paul, A. Marks, 129–139. New York: Alan R. Liss.
Gold, Michael. 1985. A Conspiracy of Cells: One Woman's Immortal Legacy and the Medical Scandal It Caused. Albany: State University of New York Press.
Golde, David. 1990. “Cell Line Ownership.” Nature 347:419.
Groopman, Jerome. 1998. “Dr. Fair's Tumor: The Promise of Tailor-Made Medicine.” The New Yorker, November 2, 78.
Haraway, Donna. 1997. Modes_Witness @/© Second—Millenium.FemaleMan—Meets—Onco Mouse™: Feminism and Technoscience. New York: Routledge.
Hayflick, L. 1961. “The Establishment of a Line (WISH) of Human Amnion Cells in Continuous Cultivation.” Experimental Cell Research 23:14–20.
Holub, Miroslav. 1990. “Tissue Culture, or about the Last Cell.” New England Review / Bread Loaf Quarterly 12:376–379.
Hsu, Susan H., Bernice, Z. Schacter, Nancy, L. Delaney, Thomas, B. Miller, Victor, A. McCusick, Kennet, R. H., Bodmer, J. G., Young, D., and Bodmer, W. F. 1976. “Genetic Characteristics of the HeLa Cell.” Science 191:392–394.
Hyde, Alan. 1997. Bodies of Law. Princeton: Princeton University Press.
Jasanoff, Sheila. 1995. Science at the Bar: Law, Science and Technology in America. Cambridge, Massachusetts: Harvard University Press.
Jones, Jr., Howard, W., Victor, A. McKusick, Peter, S. Harper, and Kuang-Dong, Wuu. 1971. “After Office Hours: The HeLa Cell and a Reappraisal of its Origin.” Obstetrics and Gynecology 38:945–949.
Kalyanaraman, V. S., Marjorie, Robert-Guroff, Isao, Miyoshi, Douglas, Blayney, David, W. Golde, Robert, C. Gallo. 1982. “A New Subtype of Human T-Cell Leukemia Virus (HTLV-II) Associated with a T-Cell Variant of Hairy Cell Leukemia.” Science 218:571–573.
Karp, Laurence. 1976. “The Immortality of a Cancer Victim Dead Since 1951.” Smithsonian Magazine, March, 51–56.
Kawaguchi, T., Mednis, A., Golde, D. W., David, J. R., Remold, H. R. 1986. “A Monoclonal Antibody against Migration Inhibitory Factor (MIF) Obtained by Immunization with MIF from the Human Lymphoblast Cell Line Mo.” J. Leukoc. Biol 39(2):223–32.
Landecker, Hannah. Forthcoming 1999. “Immortality, In Vitro: A History of the HeLa Cell Line.” In Biotechnology, Culture, and the Body, edited by Paul, Brodwin. Bloomington: Indiana University Press.
McKusick, Victor A., and Robert, Claiborne. 1973. Medical Genetics. New York: HP Publishing.
Moore, John L. 1985. “Statement of John L. Moore before the Subcommittee on Investigations and Oversight, House Committee on Science and Technology.” In Hearings on the Use of Human Patient Material in the Development of Commercial Biomedical Products, October 29, 246–278.
Moore v. Regents of the University of California, 51 Cal. 3d 120 (MC 1990).
Office of Technology Assessment (OTA) 1987. New Developments in Biotech nology: Ownership of Human Tissues and Cells-Special Report. OTA-BA-337. Washington, DC: US Government Printing Office.
Rabinow, Paul. 1992. “Severing the Ties: Fragmentation and Dignity in Late Modernity.” Knowledge and Society: The Anthropology of Science and Tech nology 9:169–187.
Saxon, Andrew, Ronald, H. Stevens, David, Golde. 1978a. “T-Lymphocyte Variant of Hairy-Cell Leukemia.” Annals of Internal Medicine 88:323–326.
Saxon, Andrew, Ronald, H. Stevens, Shirley, G. Quan, David, W. Golde. 1978b. “Immunologic Characterization of Hairy Cell Leukemias in Continuous Culture.” Journal of Immunology 120:777–782.
Shaw, George Bernard. 1959.  Man and Superman: a Comedy and a Philosophy. New York: Bantam Books.
Sun, Marjorie. 1983. “Scientists Settle Cell Line Dispute.” Science 220: 393–394.
United States Patent 4,438,032, March 20, 1984.
Williams, Patricia. 1995. The Rooster's Egg. Cambridge, Massachusetts: Harvard University Press.